These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26141958)

  • 21. Statins in primary prevention: impact on mortality. A meta-analysis study.
    Nunes JP
    Minerva Cardioangiol; 2017 Oct; 65(5):531-538. PubMed ID: 28249380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are statins effective in high-risk primary prevention?
    Dentali F; Guasti L
    Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
    [No Abstract]   [Full Text] [Related]  

  • 23. Statins in chronic kidney disease: cardiovascular risk and kidney function.
    Deedwania PC
    Postgrad Med; 2014 Jan; 126(1):29-36. PubMed ID: 24393749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.
    Brown F; Singer A; Katz A; Konrad G
    Can Fam Physician; 2017 Nov; 63(11):e495-e503. PubMed ID: 29138175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention.
    Rochlani Y; Kattoor AJ; Pothineni NV; Palagiri RDR; Romeo F; Mehta JL
    Am J Cardiol; 2017 Oct; 120(7):1122-1128. PubMed ID: 28797470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
    Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
    Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin therapy for primary prevention of cardiovascular disease.
    Taylor FC; Huffman M; Ebrahim S
    JAMA; 2013 Dec; 310(22):2451-2. PubMed ID: 24276813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based use of statins for primary prevention of cardiovascular disease.
    Minder CM; Blaha MJ; Horne A; Michos ED; Kaul S; Blumenthal RS
    Am J Med; 2012 May; 125(5):440-6. PubMed ID: 22387091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Statin therapy--for whom?].
    Kahri J; Syvänne M
    Duodecim; 2012; 128(8):811-8. PubMed ID: 22616372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Does statin therapy reduce the risk of stroke? A meta-analysis].
    Sirol M; Bouzamondo A; Sanchez P; Lechat P
    Ann Med Interne (Paris); 2001 Apr; 152(3):188-93. PubMed ID: 11431579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia: management using optimal lipid-lowering therapy.
    Ito MK
    Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Statins and ASS for primary prevention of cardiovascular and cerebrovascular disease].
    Goltz L; Bodechtel U; Siepmann T
    Dtsch Med Wochenschr; 2014 Feb; 139(6):283-6. PubMed ID: 24473850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence With Statins in Primary Prevention of Cardiovascular Disease: Findings From a Cohort of Spanish Workers.
    Malo S; Aguilar-Palacio I; Feja C; Menditto E; Lallana MJ; Andrade E; Casasnovas JA; Rabanaque MJ
    Rev Esp Cardiol (Engl Ed); 2018 Jan; 71(1):26-32. PubMed ID: 28473266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence and critique of the JUPITER Trial (Statins v no statins for primary prevention of cardiovascular events in patients with normal lipids and elevated C-reactive protein).
    Samson RH; Nair DG
    Semin Vasc Surg; 2011 Sep; 24(3):172-9. PubMed ID: 22153029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
    Chodick G; Shalev V
    Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
    [No Abstract]   [Full Text] [Related]  

  • 36. Preprocedural statin therapy in percutaneous coronary intervention.
    Cahoon WD; Crouch MA
    Ann Pharmacother; 2007 Oct; 41(10):1687-93. PubMed ID: 17712042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.
    Shalev V; Goldshtein I; Halpern Y; Chodick G
    Pharmacotherapy; 2014 Jan; 34(1):1-8. PubMed ID: 23836549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins for secondary prevention of cardiovascular disease: the right dose.
    Spector R; Snapinn SM
    Pharmacology; 2011; 87(1-2):63-9. PubMed ID: 21228612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
    Ray KK; Seshasai SR; Erqou S; Sever P; Jukema JW; Ford I; Sattar N
    Arch Intern Med; 2010 Jun; 170(12):1024-31. PubMed ID: 20585067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk.
    Nieuwkerk PT; Nierman MC; Vissers MN; Locadia M; Greggers-Peusch P; Knape LP; Kastelein JJ; Sprangers MA; de Haes HC; Stroes ES
    Am J Cardiol; 2012 Sep; 110(5):666-72. PubMed ID: 22621795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.